Obstructive nephropathy: Insights from genetically engineered animals
Open Access
- 1 September 2005
- journal article
- review article
- Published by Elsevier BV in Kidney International
- Vol. 68 (3), 925-937
- https://doi.org/10.1111/j.1523-1755.2005.00486.x
Abstract
No abstract availableThis publication has 102 references indexed in Scilit:
- Bradykinin Decreases Plasminogen Activator Inhibitor-1 Expression and Facilitates Matrix Degradation in the Renal Tubulointerstitium under Angiotensin-Converting Enzyme BlockadeJournal of the American Society of Nephrology, 2004
- Plasmin is not protective in experimental renal interstitial fibrosis1Kidney International, 2004
- Chemokines and chemokine receptors are involved in the resolution or progression of renal diseaseKidney International, 2003
- Endoglin Upregulation During Experimental Renal Interstitial Fibrosis in MiceHypertension, 2002
- Absence of Decorin Adversely Influences Tubulointerstitial Fibrosis of the Obstructed Kidney by Enhanced Apoptosis and Increased Inflammatory ReactionThe American Journal of Pathology, 2002
- Fetal rhesus monkey model of obstructive renal dysplasiaKidney International, 2001
- Molecular and cellular pathophysiology of obstructive nephropathyPediatric Nephrology, 1999
- Angiotensin II and gene expression in the kidneyAmerican Journal of Kidney Diseases, 1998
- Mechanisms for Inducible Control of Angiotensinogen Gene TranscriptionHypertension, 1996
- Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.Hypertension, 1994